Close Menu

This article has been updated from a previous version to include comments made by Qiagen CEO Peer Schatz during an earnings call.

NEW YORK (GenomeWeb) – Qiagen reported after the close of the market on Monday that its third quarter revenues grew 4 percent year over year.

For the three months ended Sept. 30, Qiagen posted revenues of $377.9 million compared to $364.0 million a year ago, falling short of the consensus Wall Street estimate of $381.1 million. On an adjusted basis and at constant exchange rates (CER), Q3 revenues rose nearly 7 percent.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The former commissioner of the FDA has returned to the venture capital firm New Enterprise Associates as a special partner on the healthcare investment team.

Astronauts have edited yeast genes on the International Space Station in an experiment designed to show how cells repair themselves in space.

Emory University has found that two of its researchers failed to divulge they had received funds from China, according to the Atlanta Journal-Constitution.

In Science this week: influence of the nuclear genome on human mitochondrial DNA, and more.